­
As a Medical Device Company what can you do to help during the COVID 19 pandemic? – Here’s what – – Elexes
Elexes Medical Consulting

Various benefits and flexibilities for Medical Device Manufacturers have been recently introduced. It’s impressive to see that within a duration of 1.5 months (between February to April 2020), the FDA has released TWENTY TWO guidance documents (many being for medical devices) to help the healthcare system cope up during these difficult times.

  1. Clinical Electronic Thermometers can now be distributed without a 510(k) clearance, establishment registration and listing, UDI, and without meeting various other obligations.
  2. All marketing authorization applications like the FDA 510ks that were put on hold and were due for a response on or before June 30, 2020 have received an automatic extension of 90 days.
  3. When alternatives like FDA-cleared masks or respirators are unavailable, FDA accepts improvised Personal Protective Equipments (PPE), and in such cases shall not object to the distribution, importation and use of improvised PPE. Similar is the case for respirators identified in the CDC recommendations. No compliance obligations are needed to be met.
  4. Modifications to FDA cleared products can be made without prior FDA approval when such modifications are being made in connection with monitoring for patients with COVID-19 or co-existing conditions and providing clinical decision support.
  5. Modifications can be made to FDA cleared products in terms of the indications, functionality, hardware, software, design, or materials to support COVID-19 patients who require sustained infusion therapy. The devices that qualify under this category are infusion pumps, syringe infusion pumps, PCA infusion pumps, and ambulatory infusion pump devices, and their accessories.
  6. Emergency Use Authorization allowed an expedited entry of multiple diagnostic devices into the market.

While exercising each of these flexibilities, the Manufacturer must ensure there is no introduction of any undue risk. 

As a medical device company, there are many more applications, expansion to indications, and benefits that you can avail and ultimately help during this situation. You can contact us to discuss further helen@elexes.com  

Leave a Reply




You may also like

Medical Devices

Clinical trials in South Africa – worldwide accepted data

Clinical trials being a resource, cost, and time extensive process, identifying the right location for a clinical trial

Medical Devices

RUO – A Market Opportunity for IVD companies

Getting an IVD product to the market is a cumbersome task and takes several months to over a year to finally get everyth

Medical Devices

Official Number is now 15 – MDD to MDR + IVDD to IVDR Planning

Everyone knows that the advent of MDR was postponed, and the new regulation shall be in full force from May 26, 2021. As

Medical Devices

Who regulates your products?

The first step towards bringing your product to the market is understanding which center at the FDA shall regulate your